3/11
10:12 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) is now covered by analysts at Bank of America Co.. They set an "underperform" rating and a $5.00 price target on the stock.
Medium
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) is now covered by analysts at Bank of America Co.. They set an "underperform" rating and a $5.00 price target on the stock.
3/4
04:45 pm
sage
Sage Therapeutics Announces R&D Leadership Transition [Yahoo! Finance]
Medium
Report
Sage Therapeutics Announces R&D Leadership Transition [Yahoo! Finance]
3/4
04:15 pm
sage
Sage Therapeutics Announces R&D Leadership Transition
Medium
Report
Sage Therapeutics Announces R&D Leadership Transition
2/25
07:07 pm
sage
Is Sage Therapeutics, Inc. (SAGE) the Best Small-Cap Growth Stock to Buy Now? [Yahoo! Finance]
Low
Report
Is Sage Therapeutics, Inc. (SAGE) the Best Small-Cap Growth Stock to Buy Now? [Yahoo! Finance]
2/13
10:56 am
sage
Sage Therapeutics price target lowered to $12 from $14 at Scotiabank [Yahoo! Finance]
Low
Report
Sage Therapeutics price target lowered to $12 from $14 at Scotiabank [Yahoo! Finance]
2/12
02:06 pm
sage
Sage Therapeutics, Inc. Price, Consensus and EPS Surprise [Yahoo! Finance]
Low
Report
Sage Therapeutics, Inc. Price, Consensus and EPS Surprise [Yahoo! Finance]
2/12
11:22 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Scotiabank from $14.00 to $12.00. They now have a "sector outperform" rating on the stock.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Scotiabank from $14.00 to $12.00. They now have a "sector outperform" rating on the stock.
2/12
11:13 am
sage
Q4 2024 SAGE Therapeutics Inc Earnings Call [Yahoo! Finance]
Low
Report
Q4 2024 SAGE Therapeutics Inc Earnings Call [Yahoo! Finance]
2/12
10:57 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
2/12
08:52 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $9.00 to $8.00. They now have a "hold" rating on the stock.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $9.00 to $8.00. They now have a "hold" rating on the stock.
2/12
08:00 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
2/12
08:00 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, down previously from $14.00.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, down previously from $14.00.
2/11
07:36 pm
sage
Sage Therapeutics, Inc. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
Low
Report
Sage Therapeutics, Inc. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
2/11
04:39 pm
sage
Sage Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Highlights Pipeline and Business Updates [Yahoo! Finance]
Low
Report
Sage Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Highlights Pipeline and Business Updates [Yahoo! Finance]
2/11
04:05 pm
sage
Sage Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Highlights Pipeline and Business Updates
Low
Report
Sage Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Highlights Pipeline and Business Updates
2/4
12:06 pm
sage
Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for [Yahoo! Finance]
Low
Report
Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for [Yahoo! Finance]
2/4
10:00 am
sage
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Connect
Low
Report
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Connect
2/3
10:00 am
sage
Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Low
Report
Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
2/2
10:00 am
sage
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Stockholders to Learn More About the Investigation
Low
Report
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Stockholders to Learn More About the Investigation
1/31
10:00 am
sage
Bronstein, Gewirtz & Grossman, LLC Encourages Sage Therapeutics, Inc. (SAGE) Investors to Inquire about Securities Investigation
Low
Report
Bronstein, Gewirtz & Grossman, LLC Encourages Sage Therapeutics, Inc. (SAGE) Investors to Inquire about Securities Investigation
1/30
07:46 pm
sage
The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen, Cytokinetics and Akero Therapeutics [Yahoo! Finance]
Low
Report
The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen, Cytokinetics and Akero Therapeutics [Yahoo! Finance]
1/30
10:30 am
sage
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Investors to Reach Out
Low
Report
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Investors to Reach Out
1/28
04:43 pm
sage
Sage Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025 [Yahoo! Finance]
Low
Report
Sage Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025 [Yahoo! Finance]
1/28
04:30 pm
sage
Sage Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025
Low
Report
Sage Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025
1/27
09:35 am
sage
Sage rejects Biogen's $469 million takeover offer [Yahoo! Finance Canada]
Low
Report
Sage rejects Biogen's $469 million takeover offer [Yahoo! Finance Canada]